Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Qingmei He"'
Autor:
Jiawei Lv, Chenfei Wu, Junyan Li, Foping Chen, Shiwei He, Qingmei He, Guanqun Zhou, Jun Ma, Ying Sun, Denghui Wei, Li Lin
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-18 (2022)
Abstract Background Significant intertumoral heterogeneity exists as antitumor treatment is introduced. Heterogeneous therapeutic responses are conventionally evaluated by imaging examinations based on Response Evaluation Criteria in Solid Tumors (RE
Externí odkaz:
https://doaj.org/article/a4696a2892e045098ded7d3190dab238
Autor:
Panpan Zhang, Qiuping He, Yaqin Wang, Guanqun Zhou, Yupei Chen, Linglong Tang, Yuan Zhang, Xiaohong Hong, Yanping Mao, Qingmei He, Xiaojing Yang, Na Liu, Jun Ma
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-11 (2022)
Abstract Metastasis and recurrence account for 95% of deaths from nasopharyngeal carcinoma (NPC). Cancer stem cells (CSCs) are regarded as one of the main reasons for tumor cell resistance to clinical therapy, and cancer metastasis or recurrence, whi
Externí odkaz:
https://doaj.org/article/179c0d2194c248109266e9b3af218321
Autor:
Yin Zhao, Shengyan Huang, Xirong Tan, Liufen Long, Qingmei He, Xiaoyu Liang, Jiewen Bai, Qingjie Li, Jiayi Lin, Yingqin Li, Na Liu, Jun Ma, Yupei Chen
Publikováno v:
Advanced Science, Vol 9, Iss 36, Pp n/a-n/a (2022)
Abstract Epitranscriptomic remodeling such as N6‐methyladenosine (m6A) modification plays a critical role in tumor development. However, little is known about the underlying mechanisms connecting m6A modification and nasopharyngeal carcinoma (NPC)
Externí odkaz:
https://doaj.org/article/e9c963e3aa884987a984b6a760e9ca1b
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Aims: This study aimed to systematically review the efficacy and safety of antioxidants for patients with Oral lichen planus (OLP).Methods: Databases, including PubMed, Web of Science, Cochrane Library, Embase, and Google Scholar, were searched up to
Externí odkaz:
https://doaj.org/article/c8e3cb896a2b4aa58fe596a85a8db075
Autor:
Yingqin Li, Xiaohong Hong, Yuan Zhang, Yingqing Li, Yuan Lei, Qingmei He, Xiaojing Yang, Yelin Liang, Jun Ma, Na Liu
Publikováno v:
Molecular Therapy: Oncolytics, Vol 22, Iss , Pp 380-387 (2021)
The immune infiltration in the tumor microenvironment has been demonstrated to be relevant to radiotherapy response. Here, we sought to understand the immune infiltration in head and neck cancer (HNC) and evaluate its significance in predicting progn
Externí odkaz:
https://doaj.org/article/94271699061548308673303d4ffb4304
Autor:
Xiaohong Hong, Na Liu, Yelin Liang, Qingmei He, Xiaojing Yang, Yuan Lei, Panpan Zhang, Yin Zhao, Shiwei He, Yaqin Wang, Junyan Li, Qian Li, Jun Ma, Yingqin Li
Publikováno v:
Molecular Cancer, Vol 19, Iss 1, Pp 1-16 (2020)
Abstract Background Circular RNAs (circRNAs), a new type of noncoding RNA (ncRNA), have been identified as significant gene expression regulators and are involved in cancer progression. However, the roles of circRNAs in nasopharyngeal carcinoma (NPC)
Externí odkaz:
https://doaj.org/article/794494f98ece45bb8b656027978e3eaf
Autor:
Panpan Zhang, Xiaomin Li, Qiuping He, Lulu Zhang, Keqing Song, Xiaojing Yang, Qingmei He, Yaqin Wang, Xiaohong Hong, Jun Ma, Na Liu
Publikováno v:
Journal of Biomedical Science, Vol 27, Iss 1, Pp 1-11 (2020)
Abstract Background The main strategy against nasopharyngeal carcinoma (NPC) is radiotherapy. However, radioresistance mediated recurrence is a leading clinical bottleneck in NPC. Revealing the mechanism of NPC radioresistance will help improve the t
Externí odkaz:
https://doaj.org/article/6471f5d85dde474cad03900a8cf35333
Autor:
Panpan Zhang, Qiuping He, Yuan Lei, Yingqin Li, Xin Wen, Mengzhi Hong, Jian Zhang, Xianyue Ren, Yaqin Wang, Xiaojing Yang, Qingmei He, Jun Ma, Na Liu
Publikováno v:
Cell Death and Disease, Vol 13, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/53c18bc5e9214615971f5eb8602c6965
Autor:
Qiuyan Chen, Linquan Tang, Na Liu, Feng Han, Ling Guo, Shanshan Guo, Jianwei Wang, Huai Liu, Yanfang Ye, Lu Zhang, Liting Liu, Pan Wang, Yingqin Li, Qingmei He, Xiaoqun Yang, Qingnan Tang, Yang Li, YuJing Liang, XueSong Sun, Chuanmiao Xie, Yunxian Mo, Ying Guo, Rui Sun, Haoyuan Mo, Kajia Cao, Xiang Guo, Musheng Zeng, Haiqiang Mai, Jun Ma
Publikováno v:
Cancer Communications, Vol 38, Iss 1, Pp 1-13 (2018)
Abstract Background Famitinib is a tyrosine kinase inhibitor against multiple targets, including vascular endothelial growth factor receptor 2/3, platelet-derived growth factor receptor, and stem cell factor receptor (c-kit). Previous studies have de
Externí odkaz:
https://doaj.org/article/46a7ad2fd04d4b9cb6f325b208958fab
Autor:
Xianyue Ren, Xiaojing Yang, Bin Cheng, Xiaozhong Chen, Tianpeng Zhang, Qingmei He, Bin Li, Yingqin Li, Xinran Tang, Xin Wen, Qian Zhong, Tiebang Kang, Musheng Zeng, Na Liu, Jun Ma
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-18 (2017)
HOPX is a transcription factor epigenetically silenced in several cancers. Here the authors, by analysing methylation profiles, identify HOPX as a suppressor of metastasis in nasopharyngeal carcinoma: mechanistically HOPX inhibitsSNAILtranscription t
Externí odkaz:
https://doaj.org/article/4d4ea197e9e44305baa10870ac7c3417